TEMECULA, Calif., April 4 /PRNewswire/ -- LifeTree eClinical(TM), a member of the FFF Enterprises Inc. family of companies and a leading provider of clinical electronic data capture and analysis systems, today announced that the company has been selected by a new sponsor for two cardiology Phase IV trials. LifeTree’s suite of clinical electronic data capture technologies and services will support the two studies, collectively involving 700 patients. Additionally important is the announcement that LifeTree was able to establish the sponsor’s first study online in two weeks, starting from a paper protocol.
According to Gary Gabriel, PhD, LifeTree’s vice president of sales and business development, “We are very pleased to have been awarded these clinical trials -- and to have launched an online study in only two weeks. We intend to provide the highest quality service as we move forward with this exciting project.
“Our client’s needs were evident,” Gabriel continued, “in their selection of LifeTree’s easy-to-use and comprehensive platform, our consultative customer services, and our rapid technology delivery. We look forward to supporting our client’s contribution to the advancement of cardiology care.”
The LifeTree eClinical suite combines study design, data entry and data reporting modules interfaced with a clinical study portal for improved data quality and study acceleration. The suite, which includes the LifeTree ICTM(TM) electronic data capture platform, is completely workflow driven and contains extensive built-in clinical trial metrics and trial management tools for designated roles throughout the clinical trial process. The LifeTree suite enables users to perform MedDRA coding; it provides automated, complete audit trails of the clinical data; and it is CDISC ODM 1.2- and 21 CFR Part 11-compliant.
About LifeTree
LifeTree eClinical, also known as LifeTree Technology LLC, is a member of the FFF Enterprises Inc. family of companies, headquartered in Temecula, California. The LifeTree suite of clinical technologies and services has been used in Phase I through IV trials, patient registries and diagnostic and epidemiological studies. For more information, call 800-211-2799 ext 1356, email info@lifetree-tech.com or visit http://www.lifetreeclinical.com/.
LifeTree eClinical
CONTACT: K-B Gressitt, VP of Marketing of LifeTree eClinical,+1-800-843-7477, ext. 1143, or +1-760-522-1064
Web site: http://www.lifetreeclinical.com/